Department of ICU, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Department of Respiratory Diseases, Nanfang Hospital, Guangzhou, China.
Arch Physiol Biochem. 2021 Jun;127(3):279-284. doi: 10.1080/13813455.2019.1634737. Epub 2019 Jul 11.
This study was aimed to investigate the associations among Chitinase 3-like 1 ( polymorphisms, asthma and plasma YKL-40 levels in Chinese population.
Four single nucleotide polymorphisms (SNPs) were genotyped. The YKL-40 level in plasma and eosinophil percentage in peripheral blood were quantified.
A SNP (rs4950928) in the promoter was associated with elevated plasma YKL-40 levels ( = .02), asthma ( = .042) and lung function ( = .029 to .002) in this Chinese population. Plasma YKL-40 levels were significantly elevated in patients with asthma compared to those in control subjects ( < .05). Plasma YKL-40 levels were significantly correlated with forced expiratory volume per cent (FEV1%) measurements ( < .05). Although plasma YKL-40 levels were decreased after treatment, the correlation with FEV1% still existed.
locus is a risk factor for asthma in Chinese population.
本研究旨在探讨中国人群几丁质酶 3 样蛋白 1( 多态性、哮喘和血浆 YKL-40 水平之间的关联。
对 4 个单核苷酸多态性(SNP)进行基因分型。定量检测血浆中 YKL-40 水平和外周血嗜酸性粒细胞百分比。
在中国人群中,启动子中的一个 SNP(rs4950928)与血浆 YKL-40 水平升高( = .02)、哮喘( = .042)和肺功能( = .029 至.002)有关。与对照组相比,哮喘患者的血浆 YKL-40 水平显著升高( < .05)。血浆 YKL-40 水平与用力呼气量百分比(FEV1%)呈显著相关性( < .05)。尽管治疗后血浆 YKL-40 水平降低,但与 FEV1% 的相关性仍然存在。
位点是中国人群哮喘的一个危险因素。